Education
About Us
Working with TipRanks
Follow Us
Pedro Granadillo Insider Profile
4 Followers
Pedro Granadillo, Director at Haemonetics, holds 54.73K shares in Rocket Pharmaceuticals (Ticker: RCKT), holds 15.34K shares in Haemonetics (Ticker: HAE), holds 0.00 shares in NPS Pharma (Ticker: NPSP).
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-23.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Pedro Granadillo holds in companies
Most Profitable Insider Trade
The most profitable trade made by Pedro Granadillo
Pedro Granadillo's Trading History
Haemonetics
Nov 09, 2018
Director
Informative Sell
1.41M
$1.15M
Rocket Pharmaceuticals
Jul 18, 2025
Director
Uninformative Buy
―
$171.86K
NPS Pharma
Feb 24, 2015
―
Uninformative Sell
1.40M
―
Dendreon Corp
Jan 07, 2014
―
Uninformative Buy
―
―
List of latest transactions for each holding click on a transaction to see Pedro Granadillo's performance on stock
You May Also Like
Pedro Granadillo insider profile FAQ
What is the percentage of profitable transactions made by Pedro Granadillo?
The percentage of profitable transactions made by Pedro Granadillo is 25%.
What is the average return per transaction made by Pedro Granadillo?
The average return per transaction made by Pedro Granadillo is -23.00%.
What stocks does Pedro Granadillo hold?
Pedro Granadillo holds: HAE, RCKT, NPSP, DNDNQ stocks.
What was Pedro Granadillo’s latest transaction?
Pedro Granadillo latest transaction was an Uninformative Buy of ―.
What was Pedro Granadillo's most profitable transaction?
Pedro Granadillo’s most profitable transaction was an Informative Sell of HAE stock on February 19, 2015. The return on the trade was 26.40%.
What is Pedro Granadillo's role in Haemonetics?
Pedro Granadillo's role in Haemonetics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.